Susan E. Nozell

3.4k total citations
44 papers, 2.7k citations indexed

About

Susan E. Nozell is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Susan E. Nozell has authored 44 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Susan E. Nozell's work include NF-κB Signaling Pathways (11 papers), Cytokine Signaling Pathways and Interactions (11 papers) and interferon and immune responses (6 papers). Susan E. Nozell is often cited by papers focused on NF-κB Signaling Pathways (11 papers), Cytokine Signaling Pathways and Interactions (11 papers) and interferon and immune responses (6 papers). Susan E. Nozell collaborates with scholars based in United States, China and Belgium. Susan E. Nozell's co-authors include Etty Benveniste, Suzanne Oparil, Dongqi Xing, Yiu-Fai Chen, Kelly L. Harms, Rajani Rajbhandari, Xinbin Chen, Braden C. McFarland, Fadi G. Hage and G. Kenneth Gray and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Susan E. Nozell

44 papers receiving 2.7k citations

Peers

Susan E. Nozell

ONCOL

IMMUN

GENET

Lucia Magnelli Italy

Olivier Coqueret France

Linda M. Boxer United States

Xuefen Le Bourhis France

Xavier Dolcet Spain

Eiichiro Nishi Japan

Almudena Porrás Spain

Yoshinori Otsuki Japan

Zhongzhou Yang China

Françoise Bono France

Lucia Magnelli Italy

Susan E. Nozell

1.4k ×0.9

612 ×0.8

ONCOL

647 ×1.2

337 ×0.6

IMMUN

344 ×1.4

GENET

Citations per year, relative to Susan E. Nozell Susan E. Nozell (= 1×) peers Lucia Magnelli

Countries citing papers authored by Susan E. Nozell

Since Specialization

Citations

This map shows the geographic impact of Susan E. Nozell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Nozell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Nozell more than expected).

Fields of papers citing papers by Susan E. Nozell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Nozell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Nozell. The network helps show where Susan E. Nozell may publish in the future.

Co-authorship network of co-authors of Susan E. Nozell

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Nozell. A scholar is included among the top collaborators of Susan E. Nozell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Nozell. Susan E. Nozell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lei, Xiaoyong, et al.. (2021). Ca2+-independent phospholipase A2β-derived PGE2 contributes to osteogenesis. Prostaglandins & Other Lipid Mediators. 158. 106605–106605. 2 indexed citations

Zhang, Zhuo, Rajani Rajbhandari, Tiffiny S. Cooper, et al.. (2018). Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition. Molecular Cancer Therapeutics. 17(5). 921–930. 14 indexed citations

Royston, Kendra J., Bidisha Paul, Susan E. Nozell, Rajani Rajbhandari, & Trygve O. Tollefsbol. (2018). Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms. Experimental Cell Research. 368(1). 67–74. 80 indexed citations

Rajbhandari, Rajani, et al.. (2016). Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors. Molecular Cancer Research. 15(3). 340–347. 15 indexed citations

Rajbhandari, Rajani, et al.. (2015). STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE. Journal of Neuroinflammation. 12(1). 128–128. 48 indexed citations

Jones, Amanda E., et al.. (2015). Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development. Development. 142(4). 722–31. 51 indexed citations

Madanecki, Piotr, Susan E. Nozell, J. Renata Ochocka, James F. Collawn, & Rafał Bartoszewski. (2014). RNAdigest: A Web-Based Tool for the Analysis and Prediction of Structure - Specific RNAse Digestion Results. PLoS ONE. 9(5). e96759–e96759. 4 indexed citations

McFarland, Braden C., G. Kenneth Gray, Susan E. Nozell, Suk W. Hong, & Etty Benveniste. (2013). Activation of the NF-κB Pathway by the STAT3 Inhibitor JSI-124 in Human Glioblastoma Cells. Molecular Cancer Research. 11(5). 494–505. 56 indexed citations

McFarland, Braden C., Suk W. Hong, Rajani Rajbhandari, et al.. (2013). NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma. PLoS ONE. 8(11). e78728–e78728. 129 indexed citations

10.

Nozell, Susan E., et al.. (2012). Protective Role of STAT3 in NMDA and Glutamate-Induced Neuronal Death: Negative Regulatory Effect of SOCS3. PLoS ONE. 7(11). e50874–e50874. 32 indexed citations

11.

Xing, Dongqi, Suzanne Oparil, Hao Yu, et al.. (2012). Estrogen Modulates NFκB Signaling by Enhancing IκBα Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-β. PLoS ONE. 7(6). e36890–e36890. 111 indexed citations

12.

McFarland, Braden C., Jingyuan Ma, Catherine P. Langford, et al.. (2011). Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma. Molecular Cancer Therapeutics. 10(12). 2384–2393. 71 indexed citations

13.

Zhao, Xueyan, et al.. (2011). An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas. Journal of Neuro-Oncology. 102(3). 367–381. 40 indexed citations

14.

Gong, Kaizheng, Yiu-Fai Chen, Peng Li, et al.. (2011). Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice. Journal of Hypertension. 29(9). 1810–1819. 39 indexed citations

15.

Oliva, Claudia R., Susan E. Nozell, Anne R. Diers, et al.. (2010). Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain. Journal of Biological Chemistry. 285(51). 39759–39767. 152 indexed citations

16.

Nozell, Susan E., et al.. (2009). The prolyl isomerase Pin1 regulates the NF-κB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene. 28(42). 3735–3745. 64 indexed citations

17.

Laver, Travis, Susan E. Nozell, & Etty Benveniste. (2008). IFN- β -Mediated Inhibition of IL-8 Expression Requires the ISGF3 Components Stat1, Stat2, and IRF-9. Journal of Interferon & Cytokine Research. 28(1). 13–23. 26 indexed citations

18.

Zhao, Xueyan, Susan E. Nozell, Zhendong Ma, & Etty Benveniste. (2007). The interferon‐stimulated gene factor 3 complex mediates the inhibitory effect of interferon‐β on matrix metalloproteinase‐9 expression. FEBS Journal. 274(24). 6456–6468. 13 indexed citations

19.

Nozell, Susan E., Zhendong Ma, Cynthia Wilson, Reesha C. Shah, & Etty Benveniste. (2004). Class II Major Histocompatibility Complex Transactivator (CIITA) Inhibits Matrix Metalloproteinase-9 Gene Expression. Journal of Biological Chemistry. 279(37). 38577–38589. 42 indexed citations

20.

Chen, Xinbin, Gang Liu, Jianhui Zhu, et al.. (2003). Isolation and Characterization of Fourteen Novel Putative and Nine Known Target Genes of the p53 Family. Cancer Biology & Therapy. 2(1). 56–63. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact